Ozturk, M. Et Al. 2016. Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test. Diagnostic Cytopathology , vol.44, no.12 , 969-974.

Ozturk, M., UMUDUM, H., Alanbay, İ., Ulubay, M., Fidan, U., Dede, M., ... Yenen, M. C.(2016). Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test. Diagnostic Cytopathology , vol.44, no.12, 969-974.

Ozturk, Mustafa Et Al. "Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test," Diagnostic Cytopathology , vol.44, no.12, 969-974, 2016

Ozturk, Mustafa Et Al. "Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test." Diagnostic Cytopathology , vol.44, no.12, pp.969-974, 2016

Ozturk, M. Et Al. (2016) . "Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test." Diagnostic Cytopathology , vol.44, no.12, pp.969-974.

@article{article, author={Mustafa Ozturk Et Al. }, title={Risk of HSIL (CIN 2–3) on colposcopic biopsy is minimal in postmenopausal women with LSIL on cytology and a negative HRHPV test}, journal={Diagnostic Cytopathology}, year=2016, pages={969-974} }